• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

David Newman, GlaxoSmithKline

Article

Pharmaceutical Executive

Pharmaceutical ExecutivePharmaceutical Executive-06-01-2008
Volume 0
Issue 0

S

David Newman

Senior Product Director, Tykerb, GlaxoSmithKline

NOTED FOR: Launch of oncology treatment Tykerb

EXCEEDED RESULTS: Treated 5,500 patients

On what motivates him to succeed:

We think we have it tough. But that's nothing compared to fighting breast cancer. These women help us put our work in perspective, and give us a sense of mission to not necessarily sell Tykerb, but instead make sure every patient gets its benefit of efficacy.

David Newman

In a therapeutic area like oncology, you have a chance to make a real difference. That focus is what keeps me motivated day in and day out.

Recent Videos
Related Content